DENSE DEPOSIT DISEASE

Clinical trials for DENSE DEPOSIT DISEASE explained in plain language.

Never miss a new study

Get alerted when new DENSE DEPOSIT DISEASE trials appear

Sign up with your email to follow new studies for DENSE DEPOSIT DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Breakthrough injection shows promise for devastating kidney conditions

Disease control Completed

This Phase 3 study tested whether pegcetacoplan injections could help people with rare kidney diseases called C3 glomerulopathy (C3G) or immune-complex membranoproliferative glomerulonephritis (IC-MPGN). The trial involved 124 participants who received either the actual drug or p…

Matched conditions: DENSE DEPOSIT DISEASE

Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

DENSE DEPOSIT DISEASE

Get alerted when new DENSE DEPOSIT DISEASE trials appear

Breakthrough injection shows promise for devastating kidney conditions